Liraglutide

Study	Reference
Broe (Controls unexposed, general pop), 2025	Broe Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211
Broe (Controls unexposed, sick), 2025	Broe Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211 Broe, A. Screening for associations between prescription drug use in pregnancy and risk of congenital malformations Pharmacoepidemiol. Drug Saf. 2020; 29:545-.
Maya, 2025	Maya Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation. JAMA 2025; :
Westergaard, 2025	Hviid, K. GLP-1 receptor agonist treatment in early pregnancy and risk of pregnancy complications - A nationwide cohort study Hum. Reprod. 2024; 39:i23-. Westergaard, D. Obesity, implantation and early pregnancy - does GLP1 play a role? Hum. Reprod. 2025; 40:i28-.